Search

Your search keyword '"Patti, F"' showing total 1,588 results

Search Constraints

Start Over You searched for: Author "Patti, F" Remove constraint Author: "Patti, F"
1,588 results on '"Patti, F"'

Search Results

152. Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis

160. Box and block test, hand grip strength and nine‐hole peg test: correlations between three upper limb objective measures in multiple sclerosis

166. Efficacy of satralizumab in subgroups of patients in SAkuraSky: A phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD)

168. Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria

169. An exploration of anger phenomenology in multiple sclerosis

170. Dimensions of care model and pediatric audiology

172. International Space Station Air Quality Assessed According to Toxicologically-Grouped Compounds

175. Diauxie and co-utilization are not exclusive during growth in nutritionally complex environments

176. Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis

177. Therapeutic lag in relapsing multiple sclerosis

178. Comparison of the effectiveness of rituximab versus alemtuzumab and natalizumab in active relapsing-remitting MS

179. Real-world experience with Ocrelizumab in the MSBase Registry

182. Real-world experience with Ocrelizumab in the MSBase Registry

183. Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression

184. Effectiveness of Natalizumab on Multiple Sclerosis patients: the Italian registry experience

186. Disorders of micturition in neurological patients; A clinical study of 786 patients

190. Tracking a mass mortality outbreak of pen shell Pinna nobilis populations: A collaborative effort of scientists and citizens

191. Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

192. Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

194. Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

195. Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

196. Erratum to 'Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study' (European Journal of Vascular and Endovascular Surgery (2017) 53(5) (617–625) (S1078588417300424) (10.1016/j.ejvs.2016.12.034))

197. Erratum to “Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study” (European Journal of Vascular and Endovascular Surgery (2017) 53(5) (617–625) (S1078588417300424) (10.1016/j.ejvs.2016.12.034))

198. Vanishing Ann Arbor

Catalog

Books, media, physical & digital resources